Home › Companies › CAPRICOR THERAPEUTICS INC. › 2024-2025

CAPRICOR THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CAPRICOR THERAPEUTICS INC.’s Form 8-K, filed May 27, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 11Ballot items
  • 144Asset managers
  • 1,244Fund votes
  • May 22, 2025Meeting date

Results at a glance

Meeting of May 22, 2025: 11 items on CAPRICOR THERAPEUTICS INC.’s Form 8-K, filed May 27, 2025: 3 approved · 8 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore CAPRICOR THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CAPRICOR THERAPEUTICS INC.

These tallies are CAPRICOR THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CAPRICOR THERAPEUTICS INC. — official shareholder meeting results, meeting held May 22, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Frank Litvack, M.D. 17,272,827---- 795,45712,481,913 96%Not verified—
Elect Director: Linda Marbán, Ph.D. 17,550,630---- 517,65412,481,913 97%Not verified—
Elect Director: David B. Musket 17,409,421---- 658,86312,481,913 96%Not verified—
Elect Director: George W. Dunbar, Jr. 14,964,520---- 3,103,76412,481,913 83%Not verified—
Elect Director: Karimah Es Sabar 10,780,431---- 7,287,85312,481,913 60%Not verified—
Elect Director: Paul Auwaerter, M.D. 17,550,804---- 517,48012,481,913 97%Not verified—
Elect Director: Philip Gotwals, Ph.D. 17,568,301---- 499,98312,481,913 97%Not verified—
Elect Director: Michael Kelliher 17,493,800---- 574,48412,481,913 97%Not verified—
2. The ratification of the appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025 29,548,484563,052438,661 ---- 98%Approved—
3. To approve the adoption of the Plan; and 9,673,7798,210,461184,044 --12,481,913 54.1%Approved—
4. To approve, by non-binding advisory vote, the resolution approving named executive officer compensation 16,442,8451,467,438158,001 --12,481,913 92%Approved—

Source: CAPRICOR THERAPEUTICS INC., Form 8-K, filed with the SEC on May 27, 2025 — read the filing on EDGAR.

How asset managers voted at the CAPRICOR THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 144 asset managers that disclosed a CAPRICOR THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Frank Litvack, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 17,272,827WITHHELD: 795,457
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Frank Litvack

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Frank Litvack, M.D.”): 17,272,827 for, 795,457 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 2,969,701 for, 4,113 withheld.

FOR
FOR: 2,969,701WITHHOLD: 4,113
Largest asset managers voting on “ELECTION OF DIRECTORS: Frank Litvack” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,4320 013For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert00 03,832Withhold
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

2. Elect Director: David B. Musket

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 17,409,421WITHHELD: 658,863
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: David Musket

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: David B. Musket”): 17,409,421 for, 658,863 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 2,973,610 for, 204 withheld.

FOR
FOR: 2,973,610WITHHOLD: 204
Largest asset managers voting on “ELECTION OF DIRECTORS: David Musket” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,4320 013For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert3,8320 00For
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

3. Elect Director: George W. Dunbar, Jr.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%WITHHELD
FOR: 14,964,520WITHHELD: 3,103,764
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: George Dunbar

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: George W. Dunbar, Jr.”): 14,964,520 for, 3,103,764 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 2,457,794 for, 516,020 withheld.

FORWITHHOLD
FOR: 2,457,794WITHHOLD: 516,020
Largest asset managers voting on “ELECTION OF DIRECTORS: George Dunbar” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock00 0438,723Withhold
State Street318,4320 013For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity23,1550 018,299Mixed
Northern Trust33,5670 00For
Equitable13,2800 014,610Mixed
Pacific Life00 012,572Withhold
ETFis Series Trust I11,4480 00For
Bridge Builder Trust00 09,469Withhold
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI00 07,200Withhold
Global X00 05,763Withhold
Columbia Threadneedle00 04,048Withhold
AIG/SunAmerica4,0350 00For
Calvert00 03,832Withhold
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

4. Elect Director: Karimah Es Sabar

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

60% Majority: yes · of votes cast

FOR 60%WITHHELD
FOR: 10,780,431WITHHELD: 7,287,853
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Karimah Es Sabar

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Karimah Es Sabar”): 10,780,431 for, 7,287,853 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 60% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 82,999 for, 2,890,815 withheld.

WITHHOLD
FOR: 82,999WITHHOLD: 2,890,815
Largest asset managers voting on “ELECTION OF DIRECTORS: Karimah Es Sabar” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 01,779,557Withhold
BlackRock00 0438,723Withhold
State Street6430 0317,802Withhold
Charles Schwab00 091,481Withhold
Lincoln Financial00 049,532Withhold
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust00 046,528Withhold
Fidelity00 041,454Withhold
Northern Trust33,5670 00For
Equitable00 027,890Withhold
Pacific Life00 012,572Withhold
ETFis Series Trust I00 011,448Withhold
Bridge Builder Trust00 09,469Withhold
AQR00 08,037Withhold
John Hancock00 07,922Withhold
ProShares00 07,251Withhold
SEI00 07,200Withhold
Global X00 05,763Withhold
Columbia Threadneedle00 04,048Withhold
AIG/SunAmerica00 04,035Withhold
Calvert00 03,832Withhold
ALPS ETF Trust00 03,521Withhold
Brighthouse00 02,989Withhold
Exchange Place Advisors Trust00 02,468Withhold
TIAA00 01,738Withhold

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

5. Elect Director: Paul Auwaerter, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 17,550,804WITHHELD: 517,480
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Paul Auwaerter

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Paul Auwaerter, M.D.”): 17,550,804 for, 517,480 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 2,973,814 for.

FOR
FOR: 2,973,814
Largest asset managers voting on “ELECTION OF DIRECTORS: Paul Auwaerter” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,4450 00For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert3,8320 00For
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

6. Elect Director: Philip Gotwals, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 17,568,301WITHHELD: 499,983
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Philip Gotwals

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Philip Gotwals, Ph.D.”): 17,568,301 for, 499,983 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 2,973,814 for.

FOR
FOR: 2,973,814
Largest asset managers voting on “ELECTION OF DIRECTORS: Philip Gotwals” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,4450 00For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert3,8320 00For
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

7. Elect Director: Michael Kelliher

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 17,493,800WITHHELD: 574,484
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Michael Kelliher

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Kelliher”): 17,493,800 for, 574,484 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 2,973,801 for, 13 withheld.

FOR
FOR: 2,973,801WITHHOLD: 13
Largest asset managers voting on “ELECTION OF DIRECTORS: Michael Kelliher” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,4320 013For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert3,8320 00For
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

8. Elect Director: Linda Marbán, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 17,550,630WITHHELD: 517,654
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Linda Marban

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Linda Marbán, Ph.D.”): 17,550,630 for, 517,654 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 2,970,940 for, 13 withheld.

FOR
FOR: 2,970,940WITHHOLD: 13
Largest asset managers voting on “ELECTION OF DIRECTORS: Linda Marban” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,4320 013For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert3,8320 00For
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
TIAA1,7380 00For
Nationwide1,3000 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

9. 3. To approve the adoption of the Plan; and

Official resultSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

54.1% Approved · of votes cast

FOR 54.1%AGAINST
FOR: 9,673,779AGAINST: 8,210,461
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: APPROVAL OF THE CAPRICOR THERAPEUTICS 2025 EQUITY INCENTIVE PLAN.

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“3. To approve the adoption of the Plan; and”): 9,673,779 for, 8,210,461 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The adoption of the Capricor Therapeutics 2025 Equity Incentive Plan was approved as follows:”
Support: 54.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of CAPRICOR THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Adopt Incentive Stock Option Plan APPROVAL OF THE CAPRICOR THERAPEUTICS 2025 EQUITY INCENTIVE PLAN.” (3 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 36 asset managers below reported 789 for, 2,924,436 against.

AGAINST
FOR: 789AGAINST: 2,924,436
Largest asset managers voting on “APPROVAL OF THE CAPRICOR THERAPEUTICS 2025 EQUITY INCENTIVE PLAN.” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard01,779,557 00Against
BlackRock0438,723 00Against
State Street589317,856 00Against
Charles Schwab091,481 00Against
Lincoln Financial049,532 00Against
Direxion Shares ETF Trust046,528 00Against
Fidelity041,454 00Against
Northern Trust033,567 00Against
Equitable027,890 00Against
Pacific Life012,572 00Against
ETFis Series Trust I011,448 00Against
Bridge Builder Trust09,469 00Against
AQR08,037 00Against
John Hancock07,922 00Against
ProShares07,251 00Against
SEI07,200 00Against
Global X05,763 00Against
Columbia Threadneedle04,048 00Against
AIG/SunAmerica04,035 00Against
Calvert03,832 00Against
ALPS ETF Trust03,521 00Against
Brighthouse02,989 00Against
Exchange Place Advisors Trust02,468 00Against
TIAA01,738 00Against
Nationwide01,300 00Against

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

10. 4. To approve, by non-binding advisory vote, the resolution approving named executive officer compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

92% Approved · of votes cast

FOR 92%
FOR: 16,442,845AGAINST: 1,467,438
Details: description as filed, official tally, votes by 144 asset managers

Description as filed by funds: APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“4. To approve, by non-binding advisory vote, the resolution approving named executive officer compensation”): 16,442,845 for, 1,467,438 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The compensation of the Company's named executive officers was approved, on a non-binding advisory basis, as follows:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 37 asset managers voting on “APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,36976 00For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert03,832 00Against
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Fund voting reports, all 37 managers: 2,969,906 for, 3,908 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 119 asset managers voting on “APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FARALLON CAPITAL MANAGEMENT LLC1,564,1900 00For
State Street967,071170 00For
BlackRock261,8115,669 00For
Point72250,5200 00For
Pier Capital, LLC188,7950 00For
Northern Trust164,3180 00For
PFM Health Sciences, LP126,7870 00For
OPPENHEIMER & CO INC123,2050 00For
Avidity Partners Management LP101,4290 00For
Charles Schwab91,5500 00For
MELLON INVESTMENTS Corp88,3270 00For
Wellington80,3990 00For
GEODE CAPITAL MANAGEMENT, LLC67,7310 00For
KENNEDY CAPITAL MANAGEMENT LLC46,580700 00For
Rafferty Asset Management, LLC46,5280 00For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM32,2130 00For
UBS3127,434 00Against
Citadel23,8590 00For
FRANKLIN ADVISERS INC23,3320 00For
Fidelity22,5830 00For
Orgel Wealth Management, LLC22,0000 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC21,9680 00For
REGENTS OF THE UNIVERSITY OF CALIFORNIA019,760 00Against
JPMorgan17,2020 00For
MONETA GROUP INVESTMENT ADVISORS LLC16,4450 00For

Institutional-manager reports, all 119 managers: 4,566,331 for, 80,952 against. Showing the 25 largest; see all in the interactive database.

11. 2. The ratification of the appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder &…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 29,548,484AGAINST: 563,052
Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: RATIFICATION OF THE SELECTION OF ROSE, SNYDER & JACOBS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.

CAPRICOR THERAPEUTICS INC.’s own tally for this item (“2. The ratification of the appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered accounting firm for the fiscal year ending December 3”): 29,548,484 for, 563,052 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 2,973,801 for, 13 against.

FOR
FOR: 2,973,801AGAINST: 13
Largest asset managers voting on “RATIFICATION OF THE SELECTION OF ROSE, SNYDER & JACOBS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIR” at CAPRICOR THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,779,5570 00For
BlackRock438,7230 00For
State Street318,43213 00For
Charles Schwab91,4810 00For
Lincoln Financial49,5320 00For
RBB FUND, INC.48,2050 00For
Direxion Shares ETF Trust46,5280 00For
Fidelity41,4540 00For
Northern Trust33,5670 00For
Equitable27,8900 00For
Pacific Life12,5720 00For
ETFis Series Trust I11,4480 00For
Bridge Builder Trust9,4690 00For
AQR8,0370 00For
John Hancock7,9220 00For
ProShares7,2510 00For
SEI7,2000 00For
Global X5,7630 00For
Columbia Threadneedle4,0480 00For
AIG/SunAmerica4,0350 00For
Calvert3,8320 00For
ALPS ETF Trust3,5210 00For
Brighthouse2,9890 00For
Exchange Place Advisors Trust2,4680 00For
TIAA1,7380 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

Largest CAPRICOR THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 45,676,887 shares outstanding at the time of that meeting.

Fund voting reports: top CAPRICOR THERAPEUTICS INC. shareholders by shares voted on “APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 3.90%
2BlackRock 0.96%
3State Street 0.70%
4Charles Schwab 0.20%
5Lincoln Financial 0.11%
6RBB FUND, INC. 0.11%
7Direxion Shares ETF Trust 0.10%
8Fidelity 0.09%
9Northern Trust 0.07%
10Equitable 0.06%
Institutional-manager reports: top CAPRICOR THERAPEUTICS INC. shareholders by shares voted on “APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS”, 2024-2025
#Asset manager % of shares outstanding
1FARALLON CAPITAL MANAGEMENT LLC 3.42%
2State Street 2.12%
3BlackRock 0.59%
4Point72 0.55%
5Pier Capital, LLC 0.41%
6Northern Trust 0.36%
7PFM Health Sciences, LP 0.28%
8OPPENHEIMER & CO INC 0.27%
9Avidity Partners Management LP 0.22%
10Charles Schwab 0.20%

Reported CAPRICOR THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

CAPRICOR THERAPEUTICS INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Nippon Shinyaku Co., Ltd. 15.52% DEF14A
SUVRETTA CAPITAL MANAGEMENT, LLC 7.48% 13G
TANG CAPITAL MANAGEMENT, LLC 7.44% 13G
BlackRock 6.45% 13F
Highbridge Capital Management, LLC and affiliated entities 6.11% DEF14A
Vanguard Group 4.96% 13F
State Street 4.03% 13F
Linda Marbán, Ph.D. 3.58% DEF14A
Frank Litvack, M.D. 2.42% DEF14A
Morgan Stanley 1.79% 13F

Percentages above are of 45,676,887 shares outstanding, as reported by CAPRICOR THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CAPRICOR THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At CAPRICOR THERAPEUTICS INC.'s shareholder meeting held May 22, 2025, in the 2024-2025 proxy season, 144 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 1,244 separate fund positions. On the most widely held item on that ballot — APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS — CAPRICOR THERAPEUTICS INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CAPRICOR THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 27, 2025.

CAPRICOR THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.